Antimicrobial Resistance: Emerging Challenges and Innovative Approaches in Clinical Practice

Abstract

Background: Antimicrobial resistance (AMR) is one of the biggest health problems in the world today. It threatens infection treatments and decades of progress in medicine. AMR is caused by overuse, abuse, and wrong prescription of antibiotics in medicine, farming, and animal care. This leads to the development of MDR, XDR, and pan-resistant bacteria that render standard treatments useless.

Objective: This research looks at the current state of AMR, the main microbe dangers, the factors that affect it, and diagnostic, therapeutic, and policy options that can be used in the real world to fight resistance.

Methods: A thorough review of all the studies that have been published, global surveillance reports (e.g., WHO, CDC), and new clinical guidelines from 2015 to 2025 were done. The studies were mainly about resistance trends, high-priority infections, and new ways to treat them.

Results: AMR problems include Gram-negative bacteria that are resistant, infections that do not respond well to treatment, and new drug research that stops moving forward. There are many things that could be done, such as rapid molecular diagnostics, antimicrobial management, bacteriophage therapy, CRISPR-based tools, and narrow-spectrum drugs.

Conclusion: AMR is a threat to health and professional care around the world. To keep antibiotics working, we need better diagnostics, targeted medicines, regulatory changes, global monitoring, and education for both doctors and patients.